These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiplatelet drugs in cardiovascular prevention: stroke prevention in patients with thrombogenic heart disease. Prescrire Int; 2000 Jun; 9(47):87-8. PubMed ID: 11010751 [Abstract] [Full Text] [Related]
3. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS. Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [Abstract] [Full Text] [Related]
6. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM. J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120 [Abstract] [Full Text] [Related]
8. Antithrombotic drugs for the secondary prevention of ischemic stroke. Nenci GG, Goracci S. Ann Ital Med Int; 2000 Sep 06; 15(4):282-90. PubMed ID: 11202630 [Abstract] [Full Text] [Related]
9. The approach to optimizing stroke care. Panagos PD. Am J Emerg Med; 2008 Sep 06; 26(7):808-16. PubMed ID: 18774049 [Abstract] [Full Text] [Related]
10. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ. Curr Med Res Opin; 2007 Jun 06; 23(6):1453-62. PubMed ID: 17559741 [Abstract] [Full Text] [Related]
19. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators. J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454 [Abstract] [Full Text] [Related]